Form 4: Ingevity Corp Director J. Kevin Willis Reports Stock Transactions
SEC Form 4 Filing
Director J. Kevin Willis of Ingevity Corp reports the acquisition of 1,816 common stock shares through deferred stock units.
Summary
- J. Kevin Willis, a director at Ingevity Corp, reported acquiring 1,297 deferred stock units (DSUs) as part of his election to receive DSUs instead of the annual non-employee director restricted stock unit grant.
- These DSUs will vest on December 17, 2025, and will convert to common stock upon termination of board service.
- Additionally, Willis acquired 519 vested DSUs in lieu of quarterly director fees, which will also convert to common stock upon termination of board service.
- The vested DSUs were valued at $43.4 per share.
- The total number of common stock shares beneficially owned by Willis after these transactions is 1,816.
Sentiment
Score: 7
Explanation: The document reflects standard director compensation practices and does not indicate any significant positive or negative events. The sentiment is neutral to slightly positive due to the alignment of director interests with the company.
Positives
- The acquisition of DSUs by a director indicates continued alignment with the company's long-term performance.
- The vesting of DSUs in the future provides an incentive for the director to remain engaged with the company.
Future Outlook
The deferred stock units will vest on December 17, 2025, and will settle into common stock upon the director's termination of board service.
Industry Context
This filing is a routine disclosure of stock transactions by a company director, which is common practice in publicly traded companies. It reflects standard compensation practices for board members.
Comparison to Industry Standards
- The use of deferred stock units (DSUs) as part of director compensation is a common practice among publicly traded companies.
- Many companies use a combination of cash and equity-based compensation to align the interests of directors with those of shareholders.
- The vesting schedule of the DSUs is typical, with vesting often tied to continued service on the board.
Stakeholder Impact
- The transactions have a minor positive impact on shareholders by aligning director interests with the company's long-term performance.
- The transactions do not have a significant impact on other stakeholders.
Key Dates
| Date | Description |
|---|---|
| 12/17/2024 | Date of the reported transactions, including the grant of DSUs and acquisition of vested DSUs. |
| 12/17/2025 | Vesting date for the deferred stock units granted in lieu of the annual non-employee director restricted stock unit grant. |
| 12/19/2024 | Date the SEC Form 4 was signed. |
Keywords
Ingevity Corp, Director, J. Kevin Willis, Deferred Stock Units, DSUs, Stock Acquisition, SEC Form 4, Director Compensation, Equity Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.